Changes in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide

BACKGROUND: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) can improve renal function and bone mineral density in people with human immunodeficiency virus (PWH). The switch can also negatively influence cholesterol, but chang...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Schafer, Jason J, Sassa, Kaitlin N, O’Connor, Jaclyn R, Shimada, Ayako, Keith, Scott W, DeSimone, Joseph A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Major Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6786703/
https://ncbi.nlm.nih.gov/pubmed/31660372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz414
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares